Table 2 Prevalence of factor V Leiden mutation and its association with SCD in Palestinian patients
Patient (n) | FV Leiden | Crude | Adjusted | ||||
|---|---|---|---|---|---|---|---|
G/G | G/A | A/A | OR (95% CI) | P value | OR (95% CI) | P value | |
SS (59) | 48 | 11 | 0 | 9.31(2.1–61.9) | 0.027 | 5.6 (1.91–39.4) | 0.039 |
AS (25) | 23 | 1 | 1 | 8.4 (1.12–64.7) | 0.038 | 3.97 (0.51–28.6) | 0.17 |
S/βThal (33) | 26 | 4 | 3 | 7.2 (0.63–75.4) | 0.19 | 3.59 (0.35–41.6) | 0.26 |
Controls | 98 | 18 | 2 | 1 | – | 1 | – |